TITLE:
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL) in the Treatment of Patients With Bipolar Depression

CONDITION:
Bipolar Disorder

INTERVENTION:
SEROQUEL (quetiapine fumarate) Tablets

SUMMARY:

      The purpose of this study is to evaluate the efficacy and safety of quetiapine in the
      treatment of a major depressive episode in patients with bipolar disorder.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 65 Years
Criteria:

        Inclusion Criteria:

          -  Written Informed Consent;

          -  Bipolar disorder with most recent episode depressed;

          -  Outpatient status

        Exclusion Criteria:

          -  Patients with a current Axis I disorder other than bipolar disorder within 6 months
             of screening;

          -  Patients whose current episode of depression exceeds 12 months or is less than 4
             weeks
      
